Katherine Whitmire
Longenecker and Associates (United States)(US)Medical Research Associates(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Health Systems, Economic Evaluations, Quality of Life, Diabetes and associated disorders, Statistical Methods in Clinical Trials
Most-Cited Works
- → Improved patient‐reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial(2022)18 cited
- → 747-P: Improved Treatment Perceptions with IGlarLixi vs. Premix Insulin in Type 2 Diabetes (T2D) Uncontrolled on Basal Insulin (BI) + Oral Antihyperglycemic Drugs (OADs): Patient-Reported Outcomes (PROs) of the SoliMix Trial(2021)3 cited
- Management of the T2D Patient With High A1C.(2019)